Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HRTX stock hub

Heron Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HRTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

228.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

HRTX

In the news

Latest news · HRTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-1.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HRTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000818033
Company name	Heron Therapeutics, Inc.
Country	United States
Country code	US
Cusip	427746102
Employees	128
Employees Change	6%
Employees Change Percent	4.92
Enterprise value	$322.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1987-08-26
Isin	US4277461020
Last refreshed	2026-05-10
Market cap	$228.3M
Market cap category	Micro-Cap
Price	$1.21
Price currency	USD
Rev Per Employee	1,210,187.5x
Sector	Healthcare
Sic	2834
Symbol	HRTX
Website	https://www.herontx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.85%
EV Sales Forward	1.81x
EV/Sales	2.08x
FCF yield	-12.23%
P/B ratio	17.15x
P/S ratio	1.47x
PS Forward	1.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.64%
EBITDA Margin	-0.14%
Gross margin	72.64%
Gross Profit	$112.5M
Gross Profit Growth	8.42%
Gross Profit Growth Q	-12.04%
Net Income	$-20.2M
Net Income Growth Years	0%
Pretax Margin	-13.04%
Profit Margin	-13.04%
Profit Per Employee	$-157,773
ROA	-0.65
Roa5y	-21.48
ROCE	-1.59
ROIC	-1.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-23.15%
Cagr15y	-7.96%
Cagr1y	-46.48%
Cagr20y	-21.36%
Cagr3y	-21.16%
Cagr5y	-40.8%
EPS Growth Years	0
Revenue Growth	7.36x
Revenue Growth Q	-0.47x
Revenue Growth Years	4x
Revenue Growth3 Y	12.89x
Revenue Growth5 Y	11.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.63
Assets	$255.9M
Cash	$46.6M
Current Assets	$238.1M
Current Liabilities	$96.1M
Debt	$140.6M
Debt Equity	$9.81
Equity	$14.3M
Interest Coverage	-0.26
Liabilities	$241.5M
Long Term Assets	$17.8M
Long Term Liabilities	$145.4M
Net Cash	$-94M
Net Cash By Market Cap	$-41.19
Net Debt Equity	$6.56
Tangible Book Value	$13.3M
Tangible Book Value Per Share	$0.07
WACC	10.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.48
Inventory Turnover	0.58
Net Working Capital	$95.3M
Quick ratio	1.42
Working Capital	$142M
Working Capital Turnover	$1.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-92.81%
1Y total return	-46.46%
200-day SMA	1.23
3Y total return	-51.01%
50-day SMA	0.98
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.72%
All Time High	1,290
All Time High Change	-99.91%
All Time High Date	1992-01-13
All Time Low	0.5
All Time Low Change	142%
All Time Low Date	2023-11-09
ATR	0.08
Beta	1.71
Beta1y	1.77
Beta2y	1.29
Ch YTD	-6.92
High	1.25
High52	2.32
High52 Date	2025-05-08
High52ch	-47.78%
Low	1.21
Low52	0.74
Low52 Date	2026-03-30
Low52ch	64.36%
Ma50ch	23.13%
Premarket Change Percent	0.81
Premarket Price	$1.25
Premarket Volume	1,838
Price vs 200-day SMA	-1.55%
RSI	60.73
RSI Monthly	41.78
RSI Weekly	51.06
Sharpe ratio	-0.7x
Sortino ratio	-0.86
Total Return	-9.35%
Tr YTD	-6.92
Tr15y	-71.19%
Tr1m	53.28%
Tr1w	-4.72%
Tr3m	-3.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$3
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	36,599,336x
Earnings Revenue Estimate Growth	-5.92x
Operating Income	$-2.5M
Operating Income Growth Q	-99.09
Operating margin	-1.64
Price target	$4.5
Price Target Change	$272
Price Target Change Top	$148

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	133,580,060%
Float Percent	70.81%
Net Borrowing	-12,755,000
Shares Insiders	0.84%
Shares Institutions	55.49%
Shares Out	188,638,866
Shares Qo Q	10.38%
Shares Yo Y	9.35%
Short Float	30.8%
Short Ratio	21.77
Short Shares	21.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-38.2M
Average Volume	2,290,014.2x
Bv Per Share	0.07
CAPEX	$-317,000
Ch10y	-92.81
Ch15y	-71.19
Ch1m	53.28
Ch1w	-4.72
Ch1y	-46.46
Ch20y	-99.18
Ch3m	-3.97
Ch3y	-51.01
Ch5y	-92.72
Ch6m	10
Change	-2.42%
Change From Open	-3.2
Close	1.24
Days Gap	0.81
Depreciation Amortization	2,314,000
Dollar Volume	2,171,522.9
Earnings Date	2026-05-11
Earnings Time	bmo
EBIT	$-2.5M
EBITDA	$-224,000
EPS	$-0.12
F Score	4
FCF	$-27.9M
FCF EV Yield	-8.66x
FCF Per Share	$-0.15
Financing CF	14,427,000
Fiscal Year End	December
Founded	1,983
Investing CF	16,009,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2014-01-13
Last Split Type	Reverse
Last10k Filing Date	2026-02-26
Ma150	1.17
Ma150ch	3.6%
Ma20	1.12
Ma20ch	8.52%
Net CF	2,845,000
Next Earnings Date	2026-05-11
Open	1.25
Optionable	Yes
Position In Range	11.11
Post Close	1.21
Postmarket Change Percent	1.55
Postmarket Price	$1.23
Ppne	12,403,000
Pre Close	1.24
Price Date	2026-05-08
Ptbv Ratio	17.18
Relative Volume	0.78x
Revenue	154,904,000x
SBC By Revenue	6.67x
Share Based Comp	10,339,000
Tr20y	-99.18%
Tr6m	10%
Us State	North Carolina
Volume	1,794,647
Z Score	-8.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HRTX pay a dividend?

Capital-return profile for this ticker.

Performance

HRTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HRTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+55.5%

Float: +70.8% of shares outstanding

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HRTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.7

Neutral momentum band

Price vs 200-day MA

-1.5%

50/200-day relationship not available

Beta (5Y)

1.71

More volatile than the market

Sharpe ratio

-0.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HRTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HRTX stock rating?

Heron Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HRTX analysis?

The full report lives at /stocks/HRTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HRTX?

The latest report frames HRTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HRTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.